1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > IVD Procedure Volumes and Pricing Analysis

IVD Procedure Volumes and Pricing Analysis

  • January 2015
  • -
  • Kalorama Information
  • -
  • 213 pages

Clinical laboratory medicine plays an integral role in healthcare and disease management, as it estimated that approximately 80% of physician's diagnoses are a result of laboratory tests. In addition to disease diagnosis, clinical lab testing is also performed to evaluate disease progression, monitor drug treatment and conditions, and determine individual therapy.

The global market for in vitro diagnostics (IVD) and clinical lab tests is strong, with a plethora of new products and rising procedure volumes through 2017. IVD Procedure Volumes and Pricing Analysis examines the global procedure volumes for IVD and laboratory tests. It covers only commercialized tests, specifically excluding those that are developmental or used primarily for research purposes. The report presents total global sales in 2014 of equipment, reagents and other products related to IVD and clinical laboratory tests.

Basic sales estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include:
Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other)
Core lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune)
Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other)
Hematology
Coagulation (PT, PTT)
Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media)
Blood Banking
Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)
Pricing trend analysis is provided for each category. For each test type, estimates are provided for the historic 2014 period and forecasts are provided through 2019. Price estimates are offered for leading products, systems and equipment; these represent average list prices but do not take into account variations between countries, discounts or rebates and other fluctuations. Wherever possible, an attempt is made to present unit prices so that procedure volumes and trends may be more easily understood.

Trends that are contributing to strong and rising utilization of IVD and clinical lab tests are discussed. These include:

aging of the global population
high and rising incidence of disease
ongoing technology development and introduction of labor-saving systems
Diagnostic laboratory technology has changed dramatically in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, automation, miniaturization and microelectronics as well as rapid development and proliferation of novel telecommunications technologies. IVD Procedure Volumes and Pricing Analysis is a unique business planning tool that tells readers which companies are performing what share of IVD procedures in this rapidly changing market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report:

Abbott Laboratories
ALERE
Arkray
Beckman Coulter, Inc./Danaher
Becton, Dickinson & Co.
bioMerieux, Inc.
Bio-RAD Laboratories, Inc.
Bio-Reference Laboratories
Clarient, Inc./GE Healthcare
Danaher Corp.
DaVita, Inc.
Genoptix, Inc./Novartis
Gen-Probe, Inc.
Hologic, Inc.
Horiba Medical
Instrumentation Laboratory
Laboratory Corporation of America
Myriad Genetics
Ortho Clinical Diagnostics
Qiagen
Quest Diagnostics
Radiometer A/S
Roche
Siemens
Spectra Laboratories
Sysmex Corp.
Thermo Fisher Scientific

Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts' reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis.

Table Of Contents

IVD Procedure Volumes and Pricing Analysis
ONE: EXECUTIVE SUMMARY
The Global In Vitro Diagnostics (IVD) and Laboratory Tests Market
Scope and Methodology
Size and Growth of the Market
Sales
Procedure Fees
Unit Test Prices
Procedure Volume
Market Trends
TWO: INTRODUCTION
Types of Tests
Venues for Test Usage
Hospitals
Physicians
Independent Clinical Laboratories
Population and Disease Demographics
World Population
Life Expectancy
Disease Incidence and Prevalence
Cancer
Diabetes
Obesity
Allergy and Asthma
Antimicrobial Drug Resistance
Regional Market Characteristics and Trends
United States
Europe
Japan
BRIC Nations
Brazil
Russia
India
China
Other Countries
THREE: POINT-OF-CARE TESTS
Overview
Types of Tests
OTC Tests
Glucose Tests
Pregnancy/Ovulation Tests
Professional Tests
Glucose Tests
Tests for Infectious Disease
Critical Care Tests
Other Tests
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
FOUR: CORE LABORATORY TESTS
Overview
Types of Tests
Clinical Chemistries
General Chemistries
Blood Gas Analysis
Urinalysis
Immunoassays
Infectious Diseases
Cardiac Markers
Tumor Markers
Diabetes
Autoimmune Diseases
Other
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
FIVE: MOLECULAR ASSAYS
Overview
Types of Tests
Infectious Disease
Oncology
Inherited Disease
Other
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
SIX: HEMATOLOGY
Overview
Types of Tests
Leading Products and Prices
Global Sales
Global Procedure Volume
Pricing Trends
Procedure Volume Trends
SEVEN: COAGULATION
Overview
Types of Tests
Prothrombin Time Testing (PT)
Activated Thromboplastin Time (PTT)
Leading Products and Prices
Global Sales
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
EIGHT: MICROBIOLOGY
Overview
Types of Tests
Automated Panels and Reagents
Manual Panels and Reagents
Blood Culture
Chromogenic Media
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
NINE: TESTS USED IN BLOOD BANKING
Overview
Types of Tests
Leading Products and Prices
Global Sales
Global Procedure Volume
Pricing Trends
Procedure Volume Trends
TEN: HISTOLOGY AND CYTOLOGY
Overview
Types of Tests
Pap Stains
Traditional Non-Pap Stains
Image Cytometry
Flow Cytometry
Immunohistochemistry and In Situ Hybridization
Circulating Tumor Cells
Leading Products and Prices
Global Sales by Test Type
Global Procedure Volume by Test Type
Pricing Trends
Procedure Volume Trends
ELEVEN: PROFILES OF KEY PLAYERS
Introduction
Abbott Laboratories
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
ALERE
Overview
Reproduction without prior written permission, in any media now in
existence or hereafter developed, in whole or in any part, is strictly prohibited
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Arkray
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Beckman Coulter, Inc./Danaher
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Becton, Dickinson and Co.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
bioMerieux, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Bio-RAD Laboratories, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Bio-Reference Laboratories
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Clarient, Inc./GE Healthcare
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Danaher Corp.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
DaVita, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Genoptix, Inc./Novartis
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Gen-Probe, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Hologic, Inc.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Horiba Medical
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Instrumentation Laboratory
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Laboratory Corporation of America
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Myriad Genetics
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Ortho Clinical Diagnostics
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Qiagen
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Quest Diagnostics
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Radiometer A/S
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Roche
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Siemens
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Spectra Laboratories
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Sysmex Corp.
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
Thermo Fisher Scientific
Overview
IVD/Lab Test Market Participation
Procedure Volume Share
Financial Snapshot
APPENDIX: COMPANY DIRECTORY
LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Table 1-1: Global IVD and Clinical Lab Sales by Market Segment in $Million,2014 – 2019 (POC [Professional], Core lab, Molecular, Hematology, Coagulation,Microbiology, Blood Banking, Histology/Cytology, Total)
Table 1-2: Global IVD Sales and Clinical Lab Sales by Market Segment in $Million, 2014 –2019 (POC [Professional], Core lab, Molecular, Hematology, Coagulation, Microbiology,Blood Banking, Histology/Cytology, Total)
Table 1-3: Global IVD and Clinical Lab Unit Test Prices by Market Segment in $, 2014 –2019 (POC [Professional], Core lab, Molecular, Hematology, Coagulation,Microbiology, Blood Banking, Histology/Cytology, Total)
Table 1-4: Global IVD and Clinical Lab Procedure Volumes by Market Segment in$Million, 2014 – 2019 (POC [Professional], Core lab, Molecular, Hematology,Coagulation, Microbiology, Blood Banking, Histology/Cytology, Total)
TWO: INTRODUCTION
Table 2-1: Types of IVD and Clinical Laboratory Tests, 2015
Table 2-2: CLIA-Registered Laboratories by Type of Facility, 2012 (Ambulance,Ambulatory Surgery Center, Ancillary Test Site, Assisted Living Facility, Blood Bank,Community Clinic, Comprehensive Outpatient Rehab, End Stage Renal Dialysis,Federally Qualified Health Center, Health Fair, Health Maintenance Organization[HMO], Home Health Agency, Hospice, Hospital, Independent Lab, Industrial Lab,Insurance-Affiliated Lab, Intermediate Care Facility for the Mentally Retarded, MobileLab, Pharmacy, Physician Office, Other Practitioner, Prison, Public Health Lab, RuralHealth Clinic, School/Student Health Service, Skilled Nursing/Nursing Facility, TissueBank/Repository, Other, Total)
Table 2-3: Global Population, 1980 – 2020
Table 2-4: U.S. Population, 1980 – 2020
Table 2-5: Selected Global Disease Statistics, January 2014 (Cardiac Diseases includinghypertension, Diabetes, Asthma, Cancer, Respiratory Infections, Chlamydia,Gonorrhea, Malaria, HIV, Maternal Conditions, Syphilis, TB)
Exhibit 2-1: Global IVD and Clinical Lab Market, 2014 (Brazil, Russia, India, China,Japan, Eastern Europe, Western Europe, U.S., Other)
THREE: POINT-OF-CARE TESTS
Table 3-1: Selected POC Tests and Prices, 2015 (OTC: Glucose, Pregnancy/ Ovulation;
Professional: Glucose, Infectious Disease, Critical Care, Other)
Table 3-2: Global POC Test Sales by Test Type in $Million, 2014 – 2019 (OTC Total,Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease,Critical Care, Other, Total POC)
Exhibit 3-1: Global POC Test Sales by Test Type in $Million, 2014 – 2019
Table 3-3: Global POC Test Procedure Volume by Test Type in Millions, 2014 – 2019(OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose,Infectious Disease, Critical Care, Other, Total POC)
Exhibit 3-2: Global POC Test Procedure Volume by Test Type in Millions, 2014 – 2019
FOUR: CORE LABORATORY TESTS
Table 4-1: Selected Core Lab Tests and Prices, 2015 (Clinical Chemistries: GeneralChemistries, Blood Gas Analysis, Urinalysis; Immunoassays: Multipurpose)
Table 4-2: Global Core Lab Test Sales by Test Type in $Million, 2014 – 2019 (ClinicalChemistries Total, General Chemistries, Blood Gas Analyzers, Urinalysis,Immunoassays Total, Infectious Disease, Cardiac Markers, Tumor Markers,Diabetes/HbA1c, Autoimmune, Other, Total Core Lab)
Exhibit 4-1: Global Core Lab Test Sales by Test Type in $Million, 2014 – 2019
Table 4-3: Global Core Lab Test Procedure Volume by Test Type in Millions,2014 – 2019 (Clinical Chemistries Total, General Chemistries, Blood Gas Analyzers,Urinalysis, Immunoassays Total, Infectious Disease, Cardiac Markers, TumorMarkers, Diabetes/HbA1c, Autoimmune, Other, Total Core Lab)
Exhibit 4-2: Global Core Lab Test Procedure Volume by Test Type in Millions,2014 – 2019
FIVE: MOLECULAR ASSAYS
Table 5-1: Selected Molecular Assay Test Services and Prices, 2015 (Infectious Disease,Oncology, Inherited Disease, Other)
Table 5-2: Global Molecular Assay Sales by Test Type in $Million, 2014 – 2019 (InfectiousDisease, Oncology, Inherited Disease, Other, Total Molecular Assays)
Exhibit 5-1: Global Molecular Assay Sales by Test Type in $Million, 2014 – 2019 (InfectiousDisease, Oncology, Inherited Disease, Other)
Table 5-3: Global Molecular Assay Procedure Volume by Test Type in Millions, 2014 –2019 (Infectious Disease, Oncology, Inherited Disease, Other, Total MolecularAssays)
Exhibit 5-2: Global Molecular Assay Procedure Volume by Test Type in Millions, 2014 –2019 (Infectious Disease, Oncology, Inherited Disease, Other)
SIX: HEMATOLOGY
Table 6-1: Selected Hematology Analyzers and Prices, 2015
Table 6-2: Global Hematology Analyzer Sales in $Million, 2014 – 2019
Exhibit 6-1: Global Hematology Analyzer Sales in $Million, 2014 – 2019
Table 6-3: Global Lab-Based Hematology Test Procedure Volume in Millions, 2014 – 201987
Exhibit 6-2: Global Lab-Based Hematology Test Procedure Volume in Millions,2014 – 2019
SEVEN: COAGULATION
Table 7-1: Selected Coagulation Analyzers and Prices, 2015
Table 7-2: Global Coagulation Analyzer Sales in $Million, 2014 – 2019
Exhibit 7-1: Global Coagulation Analyzer Sales in $Million, 2014 – 2019
Table 7-3: Global Lab-Based Coagulation Test Procedure Volume by Test Type inMillions, 2012 – 2017 (PT, PTT, Total Coagulation)
Exhibit 7-2: Global Lab-Based Coagulation Test Procedure Volume by Test Type inMillions, 2014 – 2019
EIGHT: MICROBIOLOGY
Table 8-1: Selected Lab-Based ID/AST Microbiology Instruments and Prices, 2015(Automated Panels and Reagents, Manual Panels and Reagents, Blood CultureSystems, Chromogenic Media)
Table 8-2: Global Lab-Based ID/AST Microbiology Instrument Sales by Test Type inMillions, 2014 – 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media, Total Microbiology)
Exhibit 8-1: Global Lab-Based ID/AST Microbiology Instrument Sales by Test Type inMillions, 2014 – 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media)
Table 8-3: Global Lab-Based ID/AST Microbiology Procedure Volume by Test Type inMillions, 2014 – 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media, Total Microbiology)
Exhibit 8-2: Global Lab-Based ID/AST Microbiology Procedure Volume by Test Type inMillions, 2014 – 2019 (Automated Panels and Reagents, Manual Panels and Reagents,Blood Culture, Chromogenic Media)
NINE: TESTS USED IN BLOOD BANKING
Table 9-1: Selected Blood Grouping Products and Prices, 2015
Table 9-2: Global Blood Grouping Product Sales in $Million, 2014 – 2019
Exhibit 9-1: Global Blood Grouping Product Sales in $Million, 2014 – 2019
Table 9-3: Global Blood Grouping Procedure Volume in $Million, 2014 – 2019
Exhibit 9-2: Global Blood Grouping Procedure Volume in $Million, 2014 – 2019
TEN: HISTOLOGY AND CYTOLOGY
Table 10-1: Selected Histology/Cytology Products and Prices, 2015 (Pap Stain, Non-PapStains, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)
Table 10-2: Global Histology/Cytology Sales by Test Type in $Millions, 2014 – 2019 (Pap,Non-Pap Stains, Image Cytometry, Flow Cytometry, In Situ Hybridization [ISH],Immunohistochemistry [IHC], Circulating Tumor Cells [CTCs], TotalHistology/Cytology)
Exhibit 10-1: Global Histology/Cytology Sales by Test Type in $Millions, 2014 – 2019(Pap, Non-Pap Stains, Image Cytometry, Flow Cytometry, In Situ Hybridization,Immunohistochemistry, CTCs)
Table 10-3: Global Histology/Cytology Procedure Volume by Test Type in Millions,2014 – 2019 (Pap, Non-Pap Stains, Image Cytometry, Flow Cytometry, In SituHybridization [ISH], Immunohistochemistry [IHC], Circulating Tumor Cells [CTCs],Total Histology/Cytology)
Exhibit 10-2: Global Histology/Cytology Procedure Volume by Test Type in Millions,2014 – 2019 (Pap, Non-Pap Stains, Image Cytometry, Flow Cytometry, In SituHybridization, Immunohistochemistry, CTCs)
ELEVEN: PROFILES OF KEY PLAYERS
Table 11-1: Global Sales and Procedure Volumes of the Leading Manufacturers of IVDand Clinical Lab Products and Equipment, 2014
Table 11-2: Global Procedure Fees of the Leading Clinical Laboratories, 2014
Table 11-3: Abbott Laboratories Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (POC including Glucose, Core Lab,Molecular Assays, Hematology, Histology/Cytology, Total)
Table 11-4: Abbott Laboratories Estimated Global IVD and Clinical Lab Sales byMarket Segment in $Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Histology/Cytology, Total)
Table 11-5: Alere Estimated Global IVD and Clinical Lab Procedure Volume by MarketSegment in Millions, 2014 (POC including Glucose, Total)
Table 11-6: Alere Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Total)
Table 11-7: Arkray Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, Total)
Table 11-8: Arkray Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Core Lab, Total)
Table 11-9: Beckman Coulter Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (Core Lab, Molecular Assays,Hematology, Coagulation, Histology/Cytology, Total)
Table 11-10 : Beckman Coulter Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Hematology, Coagulation,Histology/Cytology, Total)
Table 11-11: Becton Dickinson Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (Core Lab, Molecular Assays,Microbiology, Histology/Cytology, Total)
Table 11-12: Becton Dickinson Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Microbiology,Histology/Cytology, Total)
Table 11-13: bioMerieux Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Microbiology,Total)
Table 11-14: bioMerieux Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Microbiology, Total)
Table 11-15: Bio-Rad Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Blood Banking, Total)
Table 11-16: Bio-Rad Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Core Lab, Blood Banking, Total)
Table 11-17: Bio-Reference Laboratories Estimated Global IVD and Clinical LabProcedure Volume by Market Segment in Millions, 2014 (Core Lab, MolecularAssays, Hematology, Microbiology, Total)
Table 11-18: Bio-Reference Laboratories Estimated Global IVD and Clinical LabProcedure Fees by Market Segment in $Millions, 2014 (Core Lab, Molecular Assays,Hematology, Microbiology, Total)
Table 11-19: Clarient Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Total)
Table 11-20: Clarient Estimated Global IVD and Clinical Lab Procedure Fees byMarket Segment in $Millions, 2014 (Core Lab, Molecular Assays, Total)
Table 11-21: Danaher Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Molecular Assays, Microbiology,Histology/Cytology, Total)
Table 11-22: Danaher Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Molecular Assays, Microbiology, Histology/Cytology, Total)
Table 11-23: DaVita Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Hematology, Microbiology, Total)
Table 11-24: DaVita Estimated Global IVD and Clinical Lab Procedure Fees by MarketSegment in $Millions, 2014 (Core Lab, Hematology, Microbiology, Total)
Table 11-25: Genoptix Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Histology/Cytology,Total)
Table 11-26: Genoptix Estimated Global IVD and Clinical Lab Procedure Fees by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Histology/Cytology,Total)
Table 11-27: Gen-Probe Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Molecular Assays, Total)
Table 11-28: Gen-Probe Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (Core Lab, Molecular Assays, Total)
Table 11-29: Hologic Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Molecular Assays, Histology/Cytology, Total)
Table 11-30: Hologic Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Molecular Assays, Histology/Cytology, Total)
Table 11-31: Horiba Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, Hematology,Total)
Table 11-32: Horiba Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (POC including Glucose, Core Lab, Hematology, Total)
Table 11-33: Instrumentation Laboratory Estimated Global IVD and Clinical LabProcedure Volume by Market Segment in Millions, 2014 (POC including Glucose,Coagulation, Total)
Table 11-34: Instrumentation Laboratory Estimated Global IVD and Clinical Lab Salesby Market Segment in $Millions, 2014 (POC including Glucose, Coagulation, Total)
Table 11-35: Labcorp Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Coagulation, Microbiology, Histology/Cytology, Total)
Table 11-36: Labcorp Estimated Global IVD and Clinical Lab Procedure Fees by MarketSegment in $Millions, 2014 (POC including Glucose, Core Lab, Molecular Assays,Hematology, Coagulation, Microbiology, Histology/Cytology, Total)
Table 11-37: Myriad Genetics Estimated Global IVD and Clinical Lab Procedure Volumeby Market Segment in Millions, 2014 (Molecular Assays, Total)
Table 11-38: Myriad Genetics Estimated Global IVD and Clinical Lab Procedure Fees byMarket Segment in $Millions, 2014 (Molecular Assays, Total)
Table 11-39: Ortho Clinical Diagnostics Estimated Global IVD and Clinical LabProcedure Volume by Market Segment in Millions, 2014 (Core Lab, Blood Banking,Total)
Table 11-40: Ortho Clinical Diagnostics Estimated Global IVD and Clinical Lab Sales byMarket Segment in $Millions, 2014 (Core Lab, Blood Banking, Total)
Table 11-41: Qiagen Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Molecular Assay, Histology/Cytology, Total)
Table 11-42: Qiagen Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Molecular Assay, Histology/Cytology, Total)
Table 11-43: Quest Diagnostics Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (POC including Glucose, Core Lab,
Molecular Assays, Hematology, Coagulation, Microbiology, Histology/Cytology,Total)
Table 11-44: Quest Diagnostics Estimated Global IVD and Clinical Lab Procedure Feesby Market Segment in $Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Coagulation, Microbiology, Histology/Cytology, Total)
Table 11-45: Radiometer A/S Estimated Global IVD and Clinical Lab Procedure Volumeby Market Segment in Millions, 2014 (POC including Glucose, Core Lab, Total)
Table 11-46: Radiometer A/S Estimated Global IVD and Clinical Lab Sales by MarketSegment in $Millions, 2014 (POC including Glucose, Core Lab, Total)
Table 11-47: Roche Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Histology/Cytology, Total)
Table 11-48: Roche Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Core Lab, Molecular Assays,Histology/Cytology, Total)
Table 11-49: Siemens Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (POC including Glucose, Core Lab, MolecularAssays, Hematology, Coagulation, Microbiology, Total)
Table 11-50: Roche Estimated Global IVD and Clinical Lab Sales by Market Segment in$Millions, 2014 (POC including Glucose, Core Lab, Molecular Assays, Hematology,Coagulation, Microbiology, Total)
Table 11-51: Spectra Laboratories Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (POC including Glucose, Core Lab,Hematology, Microbiology, Total)
Table 11-52: Spectra Laboratories Estimated Global IVD and Clinical Lab ProcedureFees by Market Segment in $Millions, 2014 (POC including Glucose, Core Lab,Hematology, Microbiology, Total)
Table 11-53: Sysmex Estimated Global IVD and Clinical Lab Procedure Volume byMarket Segment in Millions, 2014 (Core Lab, Hematology, Coagulation, Total)
Table 11-54: Sysmex Estimated Global IVD and Clinical Lab Sales by Market Segmentin $Millions, 2014 (Core Lab, Hematology, Coagulation, Total)
Table 11-55: Thermo Fisher Scientific Estimated Global IVD and Clinical Lab ProcedureVolume by Market Segment in Millions, 2014 (Core Lab, Microbiology,Histology/Cytology, Total)
Table 11-56: Thermo Fisher Scientific Estimated Global IVD and Clinical Lab Sales byMarket Segment in $Millions, 2014 (Core Lab, Microbiology, Histology/Cytology,Total)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Clinical Lab Services Industry Market Report

2016 Clinical Lab Services Industry Market Report

  • $ 2800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Clinical Lab Services Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Clinical Lab Services industry with a focus ...

China Independent Clinical Laboratory Industry Report, 2016-2020

China Independent Clinical Laboratory Industry Report, 2016-2020

  • $ 2300
  • Industry report
  • September 2016
  • by Research In China

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory market ...

Europe Hematology and Flow Cytometry Markets 2017-2021:  France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies

Europe Hematology and Flow Cytometry Markets 2017-2021: France, Germany, Italy, Spain, UK--Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies

  • $ 12800
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800. Summary VPGMarketResearch.com's new comprehensive five-country report contains 450 pages, 160 tables, and ...


Download Unlimited Documents from Trusted Public Sources

Global Point Of Care Testing Industry - Forecast

  • October 2016
    77 pages
  • Point Of Care T...  

    Cardiovascular ...  

    Heart Attack  

  • World  

    Europe  

    United Kingdom  

View report >

Pathology Statistics in Australia - Forecast

  • September 2016
    8 pages
  • Pathology  

    Pap Smear  

    Cancer  

  • Australia  

    Oceania  

View report >

Influenza Statistics in the US

  • August 2016
    43 pages
  • Influenza  

    In Vitro Diagno...  

    Therapy  

  • United States  

    North America  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.